In November 2017, Barré-Sinoussi becomes president of Sidaction, a leading French HIV/AIDS advocacy and research-funding organization.
In November 2017, Françoise Barré-Sinoussi became president of Sidaction, one of France's most prominent organizations dedicated to funding HIV/AIDS research, supporting patients, and conducting public awareness campaigns. This appointment came nearly a decade after her Nobel Prize win and reflected her sustained commitment to translating scientific discovery into public health action.
As president, Barré-Sinoussi continued to leverage her scientific authority and global stature to advocate for sustained funding of HIV research amid competing public health priorities and, later, the emergence of new global health crises. She frequently emphasized that despite dramatic advances in antiretroviral therapy, an actual cure and an effective vaccine remained elusive goals requiring ongoing investment.
Her leadership at Sidaction paralleled her earlier role as president of the International AIDS Society (2012), reflecting a career-long pattern of moving fluidly between laboratory research and organizational leadership in the fight against HIV/AIDS. This role solidified her legacy not only as a laboratory scientist but as an influential public voice bridging biomedical research, health policy, and activism, particularly in advocating for vulnerable and marginalized populations disproportionately affected by the epidemic, including in developing countries.